Latest Financials News

Stakk Limited has expanded its partnership with T-Mobile Money, adding advanced fraud and risk modules to its embedded finance platform, potentially accelerating revenue growth within one of the largest US consumer ecosystems.

Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.

Adelong Gold Limited refutes claims by Great Divide Mining of a binding agreement to resolve their Challenger Mines joint venture dispute, leaving the matter unsettled and market watchers cautious.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

VRX Silica Limited has raised $2.1 million through a share placement to fund critical pre-construction activities at its Arrowsmith North Silica Sand Project, aiming to strengthen its position in high-quality silica sand markets.

Element 25 Limited is making significant strides in expanding its Butcherbird Manganese Mine, securing $60 million in funding and advancing critical engineering and contract milestones to boost manganese concentrate production to 1.1 million tonnes per annum.

Stealth Group Holdings has secured $19.5 million through a share placement to strengthen its balance sheet, reduce debt, and fund the integration of Hardware and Building Traders (HBT) alongside its wholesale distribution expansion.

Astron Limited has sold a significant portion of its Energy Fuels shares, generating A$15.2 million to bolster financial flexibility as it advances the pivotal Donald Project towards production.

IVE Group Limited reported a robust FY25 with significant profit growth and margin expansion, driven by strategic logistics expansions and the rising Lasoo e-commerce platform. Despite a softer FY26 start, the company maintains steady dividends and growth ambitions.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Centuria Capital Group has expanded its agriculture portfolio by acquiring Australia’s largest hydroponic glasshouse facility in South Australia for $168 million, boosting its agriculture assets under management by 25%.

Atturra Limited reported a robust 24% increase in both revenue and underlying EBITDA for FY25, propelled by its cloud platform, AI innovations, and defence sector contracts. The company forecasts continued momentum into FY26 with ambitious growth targets.